Apellis Pharmaceuticals (APLS) Q1 2026 Earnings

7MayConfirmed
Q3 2025
Q4 2025
Q1 2026
Q1 2026
-0.47
0.24
0.96
1.67

Details

Expected EPS
-0.37
Actual EPS
0.15
Surprise EPS
0.52
Surprise Percent
+140.54%

Description

Apellis Pharmaceuticals (APLS) has reported earnings of 0.15 per share for Q1 2026.

0 Comments

Share your thoughts